Company Overview
Snapshot
Founded in June 2006 by Yosi Morik, Arineta operates with 51–200 employees. The company has secured $10 million in total capital raised across one funding round. In April 2025, Arineta engaged in acquisition negotiations with major healthcare corporations Abbott and Johnson & Johnson, with a reported valuation of approximately $300 million.
Business overview
Arineta develops and produces advanced cardiovascular imaging solutions, primarily focusing on its flagship product, CardioGraphe. This dedicated single-heartbeat, whole-heart cardiac CT scanner utilizes proprietary Stereo CT technology to provide comprehensive clinical information for diagnosis and therapy planning. Optimized for imaging the entire heart and cardiovascular system with reduced radiation doses and fast scan speeds, CardioGraphe serves hospitals and clinicians in North America, Europe, China, and Israel, operating within the Health Tech & Life Sciences sector.
Strategic signal
In April 2025, Arineta entered into acquisition negotiations with Abbott and Johnson & Johnson, valuing the company at approximately $300 million. This development signals strong market validation for Arineta's CardioGraphe technology and its potential to significantly impact the cardiac imaging market, especially given its reported doubling of revenues since a previous acquisition deal was canceled.
Log in to access full profile ›Company Intelligence Q&A
- When did Arineta receive FDA approval for its cardiac CT device?
- In August 2016, Arineta received FDA approval for its cardiac mapping CT device.
- Which companies were in acquisition talks with Arineta in April 2025?
- In April 2025, Arineta was in negotiations for acquisition by two major healthcare corporations, Abbott and Johnson & Johnson.
- What was the reported valuation during the acquisition negotiations in April 2025?
- During the acquisition negotiations in April 2025, Arineta was valued at approximately $300 million.
- Has Arineta partnered with other companies for product distribution?
- Arineta's CardioGraphe is distributed globally by GE Healthcare, and the company signed a strategic agreement with GE Healthcare to market its product in August 2016.